U.S., Oct. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07215026) titled 'Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes' on Oct. 08.
Brief Summary: This is a retrospective, cross-sectional, non-interventional, multi-country survey-based chart audit study to evaluate real-world treatment patterns, patient clinical profiles, and clinical outcomes among a NSCLC patients receiving at least 1L SACT (Systemic anticancer therapy)
Study Start Date: Oct. 31
Study Type: OBSERVATIONAL
Condition:
Non-small Cell Lung Cancer
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Published by HT Digital Content Services with permission from Health Daily Dig...